Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bacterial Toxins | 5 | 2013 | 229 | 0.710 |
Why?
|
Antigens, Bacterial | 5 | 2013 | 374 | 0.670 |
Why?
|
Heart | 3 | 2007 | 1214 | 0.510 |
Why?
|
Spironolactone | 2 | 2013 | 26 | 0.460 |
Why?
|
Aldosterone | 2 | 2013 | 80 | 0.450 |
Why?
|
Coronary Angiography | 2 | 2002 | 568 | 0.320 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 42 | 0.310 |
Why?
|
Bradycardia | 1 | 2008 | 74 | 0.310 |
Why?
|
Viper Venoms | 1 | 2007 | 3 | 0.300 |
Why?
|
Thrombectomy | 1 | 2008 | 168 | 0.290 |
Why?
|
Adenylyl Cyclases | 1 | 2007 | 103 | 0.290 |
Why?
|
Shock | 1 | 2007 | 96 | 0.270 |
Why?
|
Echocardiography | 3 | 2013 | 1241 | 0.240 |
Why?
|
Coronary Vessels | 1 | 2008 | 643 | 0.230 |
Why?
|
Cardiac Catheterization | 1 | 2008 | 693 | 0.230 |
Why?
|
Hypertension | 1 | 2013 | 1624 | 0.220 |
Why?
|
Heart Ventricles | 1 | 2007 | 847 | 0.200 |
Why?
|
Rats | 6 | 2013 | 6638 | 0.190 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2002 | 78 | 0.190 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2002 | 187 | 0.180 |
Why?
|
Rats, Sprague-Dawley | 5 | 2013 | 2255 | 0.180 |
Why?
|
Myocardial Ischemia | 1 | 2002 | 434 | 0.150 |
Why?
|
Coronary Vessel Anomalies | 1 | 2002 | 269 | 0.150 |
Why?
|
Integrins | 2 | 2009 | 278 | 0.140 |
Why?
|
Heart Failure | 2 | 2010 | 2500 | 0.130 |
Why?
|
Disease Models, Animal | 2 | 2010 | 7471 | 0.110 |
Why?
|
Heart Failure, Diastolic | 1 | 2013 | 10 | 0.110 |
Why?
|
Cardiovascular Diseases | 4 | 2009 | 2307 | 0.110 |
Why?
|
Rats, Inbred WKY | 1 | 2013 | 112 | 0.110 |
Why?
|
Rats, Inbred SHR | 1 | 2013 | 113 | 0.110 |
Why?
|
Anthrax | 2 | 2009 | 37 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 557 | 0.090 |
Why?
|
Ventricular Dysfunction | 1 | 2010 | 34 | 0.090 |
Why?
|
Counterpulsation | 1 | 2010 | 4 | 0.090 |
Why?
|
Angina Pectoris | 1 | 2010 | 69 | 0.090 |
Why?
|
Norepinephrine | 1 | 2010 | 285 | 0.090 |
Why?
|
Vasoconstrictor Agents | 1 | 2010 | 167 | 0.090 |
Why?
|
Animals | 8 | 2013 | 62807 | 0.080 |
Why?
|
Cardiovascular System | 1 | 2009 | 151 | 0.070 |
Why?
|
Blood Flow Velocity | 2 | 2010 | 543 | 0.070 |
Why?
|
Mineralocorticoid Receptor Antagonists | 1 | 2006 | 33 | 0.070 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 117 | 0.070 |
Why?
|
Diastole | 1 | 2006 | 190 | 0.060 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 203 | 0.060 |
Why?
|
Sepsis | 1 | 2010 | 689 | 0.060 |
Why?
|
Signal Transduction | 3 | 2013 | 12222 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2007 | 534 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2010 | 1047 | 0.060 |
Why?
|
Stroke Volume | 1 | 2006 | 578 | 0.050 |
Why?
|
Echocardiography, Doppler | 1 | 2004 | 188 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2010 | 1373 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 898 | 0.050 |
Why?
|
Arteriosclerosis | 1 | 2003 | 185 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 544 | 0.050 |
Why?
|
Reference Values | 1 | 2004 | 1155 | 0.050 |
Why?
|
Male | 8 | 2013 | 128957 | 0.050 |
Why?
|
Electrocardiography | 1 | 2007 | 1196 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2004 | 580 | 0.040 |
Why?
|
Lipids | 1 | 2003 | 662 | 0.040 |
Why?
|
Time Factors | 2 | 2010 | 13130 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2002 | 568 | 0.040 |
Why?
|
Humans | 13 | 2010 | 271884 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2010 | 7300 | 0.040 |
Why?
|
Apoptosis | 1 | 2010 | 7837 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2010 | 31042 | 0.020 |
Why?
|
Aged | 3 | 2010 | 73471 | 0.020 |
Why?
|
Risk Factors | 1 | 2008 | 18045 | 0.020 |
Why?
|
Middle Aged | 3 | 2010 | 90395 | 0.020 |
Why?
|
Regenerative Medicine | 1 | 2010 | 40 | 0.020 |
Why?
|
Spores, Bacterial | 1 | 2009 | 46 | 0.020 |
Why?
|
Biomechanical Phenomena | 1 | 2010 | 297 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 81 | 0.020 |
Why?
|
Bacillus anthracis | 1 | 2009 | 45 | 0.020 |
Why?
|
Acute Disease | 1 | 2013 | 2514 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 710 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2010 | 482 | 0.020 |
Why?
|
Female | 4 | 2010 | 149143 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2007 | 46 | 0.020 |
Why?
|
Consumer Product Safety | 1 | 2006 | 31 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 7790 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2008 | 39780 | 0.020 |
Why?
|
Cell Membrane | 1 | 2009 | 900 | 0.020 |
Why?
|
Phosphorylation | 1 | 2013 | 4984 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 1613 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2013 | 5787 | 0.020 |
Why?
|
Hemodynamics | 1 | 2009 | 973 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 2457 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 3512 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 3078 | 0.010 |
Why?
|
Apolipoprotein A-I | 1 | 2003 | 101 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 2864 | 0.010 |
Why?
|
Apolipoproteins B | 1 | 2003 | 140 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2003 | 151 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2003 | 132 | 0.010 |
Why?
|
Amyloid | 1 | 2003 | 94 | 0.010 |
Why?
|
Blood Pressure | 1 | 2009 | 1603 | 0.010 |
Why?
|
Veins | 1 | 2003 | 166 | 0.010 |
Why?
|
Adult | 1 | 2008 | 81857 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 294 | 0.010 |
Why?
|
Triglycerides | 1 | 2003 | 622 | 0.010 |
Why?
|
Cholesterol | 1 | 2003 | 681 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2003 | 567 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 6909 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 2679 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 3853 | 0.010 |
Why?
|
Biomarkers | 1 | 2003 | 5112 | 0.010 |
Why?
|